Elanco
Research & Reports
Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society’s Growing Needs
August 3, 2026
Health & Healthcare
Credelio Quattro™ Kills Ticks(1) Faster(2) Than Simparica Trio® and NexGard® Plus
July 22, 2026
Corporate Responsibility
Elanco To Launch Elanco Ventures With $25 Million Multi-Year Commitment To Accelerate Innovation in Animal Health
June 19, 2026
Health & Healthcare
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
June 4, 2026
Corporate Responsibility
Monumental Public-Private Initiative Forms to Permanently Close America’s Protein Gap
May 27, 2026
Health & Healthcare
Diagnostics, Vet Visits, Giving Pets a Voice: Jay Mazelsky & Jay Price
May 4, 2026
Health and Wellness
Elanco’s Credelio™ (Lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) Against New World Screwworm (NWS) in Dogs
November 1, 2025
Health and Wellness
Elanco Innovation Builds Momentum, Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) Reaches Blockbuster Status
September 10, 2025
Health and Wellness
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief
June 10, 2025
Health and Wellness
Elanco Enters Agreement With Medgene To Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle
February 27, 2025
Health and Wellness
Meet the Faces of Zen: Elanco’s Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal
February 1, 2025
Employee Engagement
Compassion, Pets, People, Complexity: Dr. Emily Swiniarski & Dr. Amanda Schnitker
September 19, 2024
Sustainability
Shared Table with Jeff Simmons | Trust, Cows, Milk, Climate: Dr. Frank Mitloehner
August 20, 2024
Environmental Resources
Elanco Announces FDA Has Completed Review of Bovaer®, First-in-Class Methane-Reducing Feed Ingredient, for U.S. Dairy Industry
May 30, 2024